Inhibition of aerobic glycolysis enhances the anti‐tumor efficacy of Zoptarelin Doxorubicin in triple‐negative breast cancer cells
2019 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Inhibition of aerobic glycolysis enhances the anti‐tumor efficacy of Zoptarelin Doxorubicin in triple‐negative breast cancer cells
Gründker, C. ; Wokoun, U.; Hellriegel, M. & Emons, G. (2019)
The Journal of Obstetrics and Gynaecology Research, 45(7) pp. 1334-1342. DOI: https://doi.org/10.1111/jog.13980
